Industries > Pharma > Top 20 Vaccines Manufacturers 2019

Top 20 Vaccines Manufacturers 2019

Merck & Co., Sanofi, Pfizer, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Emergent Biosolutions, Other Companies

PUBLISHED: 12 February 2019
PAGES: 157
PRODUCT CODE: PHA0355
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0355 Categories: , Tags: , , , , ,

The global vaccines market has witnessed strong growth in past few years. The top 5 manufacturers in the global vaccines market are, Merck & Co., Inc., Sanofi, Pfizer Inc., GlaxoSmithKline PLC, and Johnson & Johnson. These companies secured about 76% revenue share in the global vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you will find 157-page report and you will receive 90 tables and 75 figures – all unavailable elsewhere.

The 157-page report provides clear detailed insight into the Top 20 Vaccines Manufacturers 2019. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
• Assessment of the leading companies in the global vaccines market:
• Astellas Pharma Inc.
• AstraZeneca
• Bavarian Nordic
• CSL Ltd.
• Emergent Biosolutions, Inc.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences
• GlaxoSmithKline PLC
• Inovio Pharmaceuticals
• Johnson & Johnson
• Merck & Co., Inc.
• Mitsubishi Tanabe Pharma Corporation
• Novavax, Inc.
• Pfizer Inc.
• Sanofi
• SELLAS Life Sciences Group, Inc.
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical

Top 20 Vaccines Manufacturers 2019

This report discusses financial outlook, product portfolio and strategic developments.

• Revenues forecast from 2017-2028 for the US, Europe and Japan Vaccines Market.

Market share of key companies in the vaccines market.

Market share of leading vaccines in the global vaccines market.

Drivers, Challenges and Opportunities for the global vaccines market.

A SWOT analysis of the global vaccines market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Top 20 Vaccines Manufacturers 2019. You find data, trends and predictions.

Buy our report today Top 20 Vaccines Manufacturers 2019: Merck & Co., Sanofi, Pfizer, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Emergent Biosolutions, Other Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Top 20 Vaccines Manufacturers 2019


Download sample pages

Complete the form below to download your free sample pages for Top 20 Vaccines Manufacturers 2019


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category